Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review
Kavita Prasad, Ethan D Borre, Lauren K Dillard, Austin Ayer, Carolina Der, Kathleen E Bainbridge, Catherine M McMahon, Debara L Tucci, Blake S Wilson, Gillian D Sanders Schmidler, James Saunders, Kavita Prasad, Ethan D Borre, Lauren K Dillard, Austin Ayer, Carolina Der, Kathleen E Bainbridge, Catherine M McMahon, Debara L Tucci, Blake S Wilson, Gillian D Sanders Schmidler, James Saunders
Abstract
Background: Hearing loss affects approximately 1·6 billion individuals worldwide. Many cases are preventable. We aimed to estimate the annual number of new hearing loss cases that could be attributed to meningitis, otitis media, congenital rubella syndrome, cytomegalovirus, and ototoxic medications, specifically aminoglycosides, platinum-based chemotherapeutics, and antimalarials.
Methods: We used a targeted and a rapid systematic literature review to calculate yearly global incidences of each cause of hearing loss. We estimated the prevalence of hearing loss for each presumed cause. For each cause, we calculated the global number of yearly hearing loss cases associated with the exposure by multiplying the estimated exposed population by the prevalence of hearing loss associated with the exposure, accounting for mortality when warranted.
Findings: An estimated 257·3 million people per year are exposed to these preventable causes of hearing loss, leading to an estimated 33·8 million new cases of hearing loss worldwide per year. Most hearing loss cases were among those with exposure to ototoxic medications (19·6 million [range 12·6 million-27·9 million] from short-course aminoglycoside therapy and 12·3 million from antimalarials). We estimated that 818 000 cases of hearing loss were caused by otitis media, 346 000 by meningitis, 114 000 by cytomegalovirus, and 59 000 by congenital rubella syndrome.
Interpretation: The global burden of preventable hearing loss is large. Hearing loss that is attributable to disease sequelae or ototoxic medications contributes substantially to the global burden of hearing loss. Prevention of these conditions should be a global health priority.
Funding: The US National Institute on Deafness and Other Communication Disorders and the US National Institute on Aging.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Source: PubMed